Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 11491
Country/Region: Côte d'Ivoire
Year: 2014
Main Partner: U.S. Centers for Disease Control and Prevention
Main Partner Program: NA
Organizational Type: Implementing Agency
Funding Agency: HHS/CDC
Total Funding: $1,978,588 Additional Pipeline Funding: N/A

NOTE: Narrative descriptions of programs were removed in COP2014. Limited summaries were released for some mechanisms on PEPFAR's Data Dashboard, but no description exists for this mechanism.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $312,017
Care: Pediatric Care and Support (PDCS) $263,437
Laboratory Infrastructure (HLAB) $650,000
Strategic Information (HVSI) $0
Treatment: Adult Treatment (HTXS) $753,134
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
LAB_ACC By site support type: Direct Service Delivery (DSD) 2015 2
LAB_ACC Number of PEPFAR-supported testing facilities (laboratories) that are recognized by national, regional, or international standards for accreditation or have achieved a minimal acceptable level towards attainment of such accreditation 2015 2
LAB_ACC Sum of Support Type disaggregates 2015 2
LAB_CAP By clinical laboratories 2015 2
LAB_CAP By site support type: Direct Service Delivery (DSD) 2015 2
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2015 2
LAB_CAP Sum of Site Support Type disaggregates 2015 2
LAB_PT CD4: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2015 2
LAB_PT CD4: Number of laboratories that participate in this PT program 2015 2
LAB_PT CD4: Number of laboratories that perform this testing 2015 2
LAB_PT Early infant diagnostics: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2015 1
LAB_PT Early infant diagnostics: Number of laboratories that participate in this PT program 2015 1
LAB_PT Early infant diagnostics: Number of laboratories that perform this testing 2015 1
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2015 2
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that participate in this PT program 2015 2
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that perform this testing 2015 2
LAB_PT HIV viral load: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2015 1
LAB_PT HIV viral load: Number of laboratories that participate in this PT program 2015 1
LAB_PT HIV viral load: Number of laboratories that perform this testing 2015 1
LAB_PT Percentage of laboratories and POC testing sites that perform HIV diagnostic testing that participate and successfully pass in an analyte-specific proficiency testing (PT) program 2015 1
SITE_SUPP By program area/support type: Lab Direct Service Delivery (DSD) 2015 2
SITE_SUPP Number of unique sites supported by PEPFAR 2015 2
Key Issues Identified in Mechanism
enumerations.Malaria (PMI)
Child Survival Activities
Safe Motherhood
Tuberculosis